194 related articles for article (PubMed ID: 23717701)
1. Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice.
Küster T; Hermann C; Hemphill A; Gottstein B; Spiliotis M
PLoS Negl Trop Dis; 2013; 7(5):e2235. PubMed ID: 23717701
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
5. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
Stadelmann B; Rufener R; Aeschbacher D; Spiliotis M; Gottstein B; Hemphill A
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004535. PubMed ID: 26967740
[TBL] [Abstract][Full Text] [Related]
6. Impact of Albendazole on Cytokine and Chemokine Response Profiles in
Wu J; Ma HZ; Apaer S; Anweier N; Zeng Q; Fulati X; Li T; Zhao JM; Wen H; Tuxun T
Biomed Res Int; 2021; 2021():6628814. PubMed ID: 34041299
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.
Joekel DE; Lundström-Stadelmann B; Müllhaupt B; Hemphill A; Deplazes P
Exp Parasitol; 2018 May; 188():65-72. PubMed ID: 29625098
[TBL] [Abstract][Full Text] [Related]
9. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
Hemphill A; Spicher M; Stadelmann B; Mueller J; Naguleswaran A; Gottstein B; Walker M
Parasitology; 2007 Nov; 134(Pt 12):1657-70. PubMed ID: 17631693
[TBL] [Abstract][Full Text] [Related]
10. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
11. Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.
Ricken FJ; Nell J; Grüner B; Schmidberger J; Kaltenbach T; Kratzer W; Hillenbrand A; Henne-Bruns D; Deplazes P; Moller P; Kern P; Barth TFE
PLoS Negl Trop Dis; 2017 May; 11(5):e0005636. PubMed ID: 28542546
[TBL] [Abstract][Full Text] [Related]
12. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.
Küster T; Stadelmann B; Aeschbacher D; Hemphill A
Int J Antimicrob Agents; 2014 Apr; 43(4):335-42. PubMed ID: 24646943
[TBL] [Abstract][Full Text] [Related]
13. Treatment of echinococcosis: albendazole and mebendazole--what else?
Hemphill A; Stadelmann B; Rufener R; Spiliotis M; Boubaker G; Müller J; Müller N; Gorgas D; Gottstein B
Parasite; 2014; 21():70. PubMed ID: 25526545
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
16. Oral Delivery of Anti-Parasitic Agent-Loaded PLGA Nanoparticles: Enhanced Liver Targeting and Improved Therapeutic Effect on Hepatic Alveolar Echinococcosis.
Li J; Yang Y; Han X; Li J; Tian M; Qi W; An H; Wu C; Zhang Y; Han S; Duan L; Wang W; Zhang W
Int J Nanomedicine; 2023; 18():3069-3085. PubMed ID: 37312930
[TBL] [Abstract][Full Text] [Related]
17. Molecular survival strategies of Echinococcus multilocularis in the murine host.
Gottstein B; Haag K; Walker M; Matsumoto J; Mejri N; Hemphill A
Parasitol Int; 2006; 55 Suppl():S45-9. PubMed ID: 16352460
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis.
Gui WF; Xu S; Dang ZS; Zhao YM
J Parasitol; 2019 Feb; 105(1):146-154. PubMed ID: 30807708
[TBL] [Abstract][Full Text] [Related]
19. Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.
Weingartner M; Stücheli S; Jebbawi F; Gottstein B; Beldi G; Lundström-Stadelmann B; Wang J; Odermatt A
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009192. PubMed ID: 35030165
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.
Küster T; Kriegel N; Boykin DW; Stephens CE; Hemphill A
Antimicrob Agents Chemother; 2013 Aug; 57(8):3829-35. PubMed ID: 23716058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
